Cauci Sabina, Maione Vincenzo, Buligan Cinzia, Linussio Martina, Serraino Diego, Stinco Giuseppe
Department of Medicine, University of Udine, Udine 33100, Italy.
Dermatology Clinic University Hospital of Brescia, Brescia 25123, Italy.
Cancer Biol Med. 2017 Aug;14(3):302-318. doi: 10.20892/j.issn.2095-3941.2017.0064.
: To investigate whether vitamin D receptor gene () BsmI-rs1544410 and FokI-rs2228570 polymorphisms, smoking duration, and body mass index (BMI) are risk factors for cutaneous melanoma, especially metastatic melanoma.
: We studied 120 cutaneous melanoma cases [68 stage I and II non-metastatic melanoma (NMetM) patients, plus 52 Stage III and IV metastatic melanoma (MetM) patients], and 120 matching healthy controls from northeast Italy. polymorphisms were measured by restriction fragment length polymorphism analysis. Absence or presence of BsmI and FokI restriction sites was denoted by " B" and " F" or by " b" and " f," respectively.
: -BsmI bb genotype was more frequent among MetM (32.7%) than among NMetM cases (13.2%), with odds ratio (OR)=3.18. Comparison of all melanoma patients healthy controls showed that the following biomarkers were at risk: ≥20 years of smoking (OR=2.43); ≥20 years of smoking combined with bb (OR=4.78), Bb+bb (OR=2.30), Ff (OR=3.04), and Ff+ff (OR=3.08); obesity (BMI>30 kg/m) alone (OR=3.54); and obesity combined with Bb+bb (OR=3.52), Ff (OR=4.78), and Ff+ff (OR=6.56). Comparison of MetM NMetM patients revealed that the following biomarkers were at risk: ≥20 years of smoking (OR=2.39), ≥20 years of smoking combined with bb (OR=5.13), Bb+bb (OR=3.07), and Ff+ff (OR=2.66); and obesity combined with Bb+bb (OR=5.27), Ff (OR=6.28), and Ff+ff (OR=9.18). Triple combination of ≥20 years of smoking, obesity, and Bb+bb yielded OR=9.65 for melanoma patients healthy controls and OR=12.2 for MetM . NMetM patients.
: Risk factors for cutaneous MetM include two polymorphisms combined with smoking duration and obesity. Results suggest gene-environment implications in melanoma susceptibility and severity. Future studies in larger cohorts and in subjects with different genetic background are warranted to extend our findings.
研究维生素D受体基因()BsmI - rs1544410和FokI - rs2228570多态性、吸烟持续时间和体重指数(BMI)是否为皮肤黑色素瘤尤其是转移性黑色素瘤的危险因素。
我们研究了120例皮肤黑色素瘤患者[68例I期和II期非转移性黑色素瘤(NMetM)患者,外加52例III期和IV期转移性黑色素瘤(MetM)患者],以及来自意大利东北部的120名匹配的健康对照者。通过限制性片段长度多态性分析来检测多态性。BsmI和FokI限制性位点的有无分别用“B”和“F”或“b”和“f”表示。
-BsmI bb基因型在MetM患者中(32.7%)比在NMetM患者中(13.2%)更常见,优势比(OR)=3.18。所有黑色素瘤患者与健康对照者的比较显示,以下生物标志物存在风险:吸烟≥20年(OR = 2.43);吸烟≥20年合并bb(OR = 4.78)、Bb + bb(OR = 2.30)、Ff(OR = 3.04)以及Ff + ff(OR = 3.08);单纯肥胖(BMI>30 kg/m)(OR = 3.54);肥胖合并Bb + bb(OR = 3.52)、Ff(OR = 4.78)以及Ff + ff(OR = 6.56)。MetM患者与NMetM患者的比较显示,以下生物标志物存在风险:吸烟≥20年(OR = 2.39);吸烟≥20年合并bb(OR = 5.13)、Bb + bb(OR = 3.07)以及Ff + ff(OR = 2.66);肥胖合并Bb + bb(OR = 5.27)、Ff(OR = 6.28)以及Ff + ff(OR = 9.18)。吸烟≥20年、肥胖和Bb + bb的三联组合在黑色素瘤患者与健康对照者中的OR = 9.65,在MetM患者与NMetM患者中的OR = 12.2。
皮肤MetM的危险因素包括两种多态性与吸烟持续时间和肥胖的联合。结果提示基因 - 环境因素对黑色素瘤易感性和严重程度有影响。有必要在更大的队列和具有不同遗传背景的受试者中开展进一步研究以扩展我们的发现。